This approach helps researchers: Reduce gastrointestinal responses Improve protocol consistency Observe biological adaptation over time Standardize experimental conditions Because dosage often increases gradually, appetite-related changes may become more apparent only after several weeks
Signs include widespread hives (not just at the injection site), difficulty breathing, swelling of the face or throat, rapid heartbeat, or severe dizziness
Sanyal and colleagues reported that 63% of Wegovy recipients experienced resolution of steatohepatitis (liver inflammation due to fat accumulation) without worsening fibrosis, compared with 34% in the placebo group
Mohammad Aqueel Ahmed at Q Day Walk-In Clinic & Spa is dedicated to providing personalized care to help you manage your weight and achieve your health goals
In February 2021, the researchers published the findings from their trial in The New England Journal of Medicine, showing that patients using semaglutide lost almost 15% of their body weight, on average, compared with 2.4% among patients who got the placebo
